Literature DB >> 14657306

Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging.

Henry Rusinek1, Susan De Santi, Dina Frid, Wai-Hon Tsui, Chaim Y Tarshish, Antonio Convit, Mony J de Leon.   

Abstract

PURPOSE: To determine if medial temporal lobe (MTL) atrophy rate, assessed by using an automated procedure over the initial time interval of a 6-year, three-time-point longitudinal study, is predictive of future memory decline.
MATERIALS AND METHODS: Healthy elderly subjects (age, >60 years) were administered a comprehensive battery of neuropsychometric tests and underwent magnetic resonance (MR) imaging at baseline and two or more follow-up examinations. The rate of brain atrophy between the baseline and first follow-up examinations was assessed by using an automated procedure that included spatial coregistration of the two images and regional brain boundary shift analysis. At final observation, the 45 subjects were separated into a group of those who did and a group of those who did not show objective evidence of cognitive decline. A forward stepwise logistic regression model was used to identify variables that predicted decline.
RESULTS: Thirty-two subjects remained healthy, and 13 showed cognitive decline. Among subjects who showed cognitive decline, six declined after the second observation. MTL atrophy rate, through its interactions with sex and age, was the most significant predictor of decline. The overall accuracy of prediction was 89% (in 40 of 45 subjects), with 91% specificity (in 29 of 32 subjects) and 85% sensitivity (in 11 of 13 subjects).
CONCLUSION: Among healthy elderly individuals, increased MTL atrophy rate appears to be predictive of future memory decline.

Entities:  

Mesh:

Year:  2003        PMID: 14657306     DOI: 10.1148/radiol.2293021299

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  99 in total

1.  Surgery and brain atrophy in cognitively normal elderly subjects and subjects diagnosed with mild cognitive impairment.

Authors:  Richard P Kline; Elizabeth Pirraglia; Hao Cheng; Susan De Santi; Yi Li; Michael Haile; Mony J de Leon; Alex Bekker
Journal:  Anesthesiology       Date:  2012-03       Impact factor: 7.892

2.  Normal age-related brain morphometric changes: nonuniformity across cortical thickness, surface area and gray matter volume?

Authors:  Herve Lemaitre; Aaron L Goldman; Fabio Sambataro; Beth A Verchinski; Andreas Meyer-Lindenberg; Daniel R Weinberger; Venkata S Mattay
Journal:  Neurobiol Aging       Date:  2010-08-23       Impact factor: 4.673

3.  Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease.

Authors:  Leonel E Rojo; Jans Alzate-Morales; Iván N Saavedra; Peter Davies; Ricardo B Maccioni
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Trajectories of brain aging in middle-aged and older adults: regional and individual differences.

Authors:  Naftali Raz; Paolo Ghisletta; Karen M Rodrigue; Kristen M Kennedy; Ulman Lindenberger
Journal:  Neuroimage       Date:  2010-03-16       Impact factor: 6.556

5.  Information-Theoretic Characterization of Blood Panel Predictors for Brain Atrophy and Cognitive Decline in the Elderly.

Authors:  Sarah K Madsen; Greg Ver Steeg; Adam Mezher; Neda Jahanshad; Talia M Nir; Xue Hua; Boris A Gutman; Aram Galstyan; Paul M Thompson
Journal:  Proc IEEE Int Symp Biomed Imaging       Date:  2015-04

6.  Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.

Authors:  Anja Soldan; Corinne Pettigrew; Yi Lu; Mei-Cheng Wang; Ola Selnes; Marilyn Albert; Timothy Brown; J Tilak Ratnanather; Laurent Younes; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2015-04-16       Impact factor: 5.038

7.  Longitudinal CSF isoprostane and MRI atrophy in the progression to AD.

Authors:  M J de Leon; L Mosconi; J Li; S De Santi; Y Yao; W H Tsui; E Pirraglia; K Rich; E Javier; M Brys; L Glodzik; R Switalski; L A Saint Louis; D Pratico
Journal:  J Neurol       Date:  2007-11-14       Impact factor: 4.849

8.  BIOMARKER CHANGE-POINT ESTIMATION WITH RIGHT CENSORING IN LONGITUDINAL STUDIES.

Authors:  Xiaoying Tang; Michael I Miller; Laurent Younes
Journal:  Ann Appl Stat       Date:  2017-09       Impact factor: 2.083

9.  Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults.

Authors:  Niklas Mattsson; Philip Insel; Rachel Nosheny; John Q Trojanowski; Leslie M Shaw; Clifford R Jack; Duygu Tosun; Michael Weiner
Journal:  Neurobiol Aging       Date:  2013-10-01       Impact factor: 4.673

10.  [Alzheimer's disease and vascular dementia. Determination of atrophy of the corpus callosum and cerebral cortex].

Authors:  T Möller; C Born; M F Reiser; H-J Möller; H Hampel; S J Teipel
Journal:  Nervenarzt       Date:  2009-01       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.